πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 115 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11819575

Manufacturing of bupivacaine multivesicular liposomes

Pacira Pharmaceuticals, Inc. Β· Granted Tue Nov 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11819573

Treatment of hip pain with sustained-release liposomal anesthetic compositions

Pacira Pharmaceuticals, Inc. Β· Granted Tue Nov 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11813357

Treatment of hip pain with sustained-release liposomal anesthetic compositions

Pacira Pharmaceuticals, Inc. Β· Granted Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11814444

Cyclic polypeptides for PCSK9 inhibition

RA PHARMACEUTICALS, INC. Β· Granted Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11814445

Cyclic polypeptides for PCSK9 inhibition

RA PHARMACEUTICALS, INC. Β· Granted Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11759459

Treatment of pain by subarachnoid administration of sustained-release liposomal anesthetic

Pacira Pharmaceuticals, Inc. Β· Granted Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11752190

Modulators of complement activity

RA PHARMACEUTICALS, INC. Β· Granted Tue Sep 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11723949

Modulators of complement activity

RA PHARMACEUTICALS, INC. Β· Granted Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11707503

Modulators of complement activity

RA PHARMACEUTICALS, INC. Β· Granted Tue Jul 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11535650

Modulation of complement activity

RA PHARMACEUTICALS, INC. Β· Granted Tue Dec 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11530244

Cyclic polypeptides for PCSK9 inhibition

RA PHARMACEUTICALS, INC. Β· Granted Tue Dec 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11505575

Cyclic polypeptides for PCSK9 inhibition

RA PHARMACEUTICALS, INC. Β· Granted Tue Nov 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11452691

Compositions of bupivacaine multivesicular liposomes

Pacira Pharmaceuticals, Inc. Β· Granted Tue Sep 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11426348

Compositions of bupivacaine multivesicular liposomes

Pacira Pharmaceuticals, Inc. Β· Granted Tue Aug 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11357727

Manufacturing of bupivacaine multivesicular liposomes

Pacira Pharmaceuticals, Inc. Β· Granted Tue Jun 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11311486

Manufacturing of bupivacaine multivesicular liposomes

Pacira Pharmaceuticals, Inc. Β· Granted Tue Apr 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11304904

Manufacturing of bupivacaine multivesicular liposomes

Pacira Pharmaceuticals, Inc. Β· Granted Tue Apr 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11278494

Manufacturing of bupivacaine multivesicular liposomes

Pacira Pharmaceuticals, Inc. Β· Granted Tue Mar 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11185506

Manufacturing of bupivacaine multivesicular liposomes

Pacira Pharmaceuticals, Inc. Β· Granted Tue Nov 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11179336

Manufacturing of bupivacaine multivesicular liposomes

Pacira Pharmaceuticals, Inc. Β· Granted Tue Nov 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11123399

Modulators of complement activity

RA PHARMACEUTICALS, INC. Β· Granted Tue Sep 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11040011

Zinc meloxicam complex microparticle multivesicular liposome formulations and processes fo

Pacira Pharmaceuticals, Inc. Β· Granted Tue Jun 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11033495

Manufacturing of bupivacaine multivesicular liposomes

Pacira Pharmaceuticals, Inc. Β· Granted Tue Jun 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11014965

Modulation of complement activity

RA PHARMACEUTICALS, INC. Β· Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted